Emergent BioSolutions CFO Richard Lindahl to retire end of 2026

Emergent BioSolutions Inc. (NYSE: EBS) announced that Richard S. Lindahl, executive vice president and chief financial officer, will retire from the company effective December 31, 2026.

Frank Vargo, currently vice president and treasurer, will take on the role of interim chief financial officer beginning January 1, 2027. Lindahl will remain with the company as a senior executive advisor through March 31, 2027 to support the transition.

Lindahl joined Emergent in 2018. Prior to that, he served as CFO of CEB, senior vice president and treasurer of Sprint Nextel Corporation, and vice president of finance at Pocket Communications, Inc. He also held positions at MCI Communications Corp. and Deloitte & Touche LLP. He currently serves on the board of directors of Compass Therapeutics, Inc.

Joe Papa, president and chief executive officer of Emergent, said: "Since joining Emergent in 2019, Frank has been integral in driving our strategic priorities forward, and I am confident he will ensure continuity and disciplined financial stewardship as interim chief financial officer."

Lindahl commented: "During my nearly nine years at Emergent, I am proud of the contributions our team made to the Company's growth, the resilience we demonstrated through some extraordinarily challenging periods, and the progress we made in strengthening the business for the future."

You May Also Be Interested In

• Digital Brands Group names Todd Kucinski VP of sports partnerships
• ImmunityBio reports 3-year bladder preservation data for Anktiva plus BCG
• Copart completes $10.50-per-share acquisition of ACV Auctions